|
⚲
|
| Keyboard |
| Gano Kyle
✚
|
|
|---|---|
| CIK # | 0001567160 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001567160] | |
| 4 | [0001567160] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Neurocrine Biosciences Inc | |
| Gano Kyle |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 2,566 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2026-02-13 | Grant | 114,830 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Grant | 20,142 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Grant | 9,968 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 2,241 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 5,378 | $124.12 | 667,517 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 1,385 | $124.12 | 171,906 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 2,566 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 2,241 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 1,210 | $124.12 | 150,185 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-12 | Option exercise | 4,907 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-12 | Option exercise | 4,907 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-12 | Tax withheld | 2,648 | $123.10 | 325,969 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-01-31 | Option exercise | 2,927 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Tax withheld | 1,580 | $136.06 | 214,975 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Option exercise | 2,927 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2026-01-16 | Option exercise | 34,588 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-16 | Sell | 1,812 | $132.71 | 240,471 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-16 | Option exercise | 1,812 | $35.99 | 65,214 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-16 | Option exercise | 34,588 | $35.99 | 1,244,822 |
| showing 20 of 177 most recent transactions | |||||